{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:27:35Z","timestamp":1790144855134,"version":"4.0.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Shiga-toxin (Stx)-producing\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    hemolytic-uremic syndrome (STEC-HUS) is one of the most common causes of acute kidney injury in children. Stx-mediated endothelial injury initiates the cascade leading to thrombotic microangiopathy (TMA), still the exact pathogenesis remains elusive. Interestingly, there is wide variability in clinical presentation and outcome. One explanation for this could be the enhancement of TMA through other factors. We hypothesize that heme, as released during extensive hemolysis, contributes to the etiology of TMA. Plasma levels of heme and its scavenger hemopexin and degrading enzyme heme-oxygenase-1 (HO-1) were measured in 48 STEC-HUS patients. Subsequently, the effect of these disease-specific heme concentrations, in combination with Stx, was assessed on primary human glomerular microvascular endothelial cells (HGMVECs). Significantly elevated plasma heme levels up to 21.2 \u00b5M were found in STEC-HUS patients compared to controls and were inversely correlated with low or depleted plasma hemopexin levels (R\n                    <jats:sup>2<\/jats:sup>\n                    \u22120.74). Plasma levels of HO-1 are significantly elevated compared to controls. Interestingly, especially patients with high heme levels (n = 12, heme levels above 75 quartile range) had high plasma HO-1 levels with median of 332.5 (86\u2013720) ng\/ml (p = 0.008). Furthermore, heme is internalized leading to a significant increase in reactive oxygen species production and stimulated both nuclear translocation of NF-\u03baB and increased levels of its target gene (tissue factor). In conclusion, we are the first to show elevated heme levels in patients with STEC-HUS. These increased heme levels mediate endothelial injury by promoting oxidative stress and a pro-inflammatory and pro-thrombotic state. Hence, heme may be a contributing and driving factor in the pathogenesis of STEC-HUS and could potentially amplify the cascade leading to TMA.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2020.547406","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T02:39:13Z","timestamp":1608604753000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome"],"prefix":"10.3389","volume":"11","author":[{"given":"Kioa L.","family":"Wijnsma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan T.","family":"Veissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sem","family":"de Wijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena B.","family":"Volokhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A. D. T. G.","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole. C. A. J.","family":"van de Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. P.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs279","article-title":"Thrombotic microangiopathy and associated renal disorders","volume":"27","author":"Barbour","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00281-014-0416-x","article-title":"Hemolytic uremic syndrome","volume":"36","author":"Mele","year":"2014","journal-title":"Semin Immunopathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71144-2","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12546","article-title":"Haemolytic uraemic syndrome","volume":"281","author":"Karpman","year":"2017","journal-title":"J Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.196","article-title":"Renal and neurological involvement in typical Shiga toxin-associated HUS","volume":"8","author":"Trachtman","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2016.01.004","article-title":"Heme: Modulator of Plasma Systems in Hemolytic Diseases","volume":"22","author":"Roumenina","year":"2016","journal-title":"Trends Mol Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v98.6.1802","article-title":"Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase","volume":"98","author":"Wagener","year":"2001","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1124\/pr.55.3.5","article-title":"Different faces of the heme-heme oxygenase system in inflammation","volume":"55","author":"Wagener","year":"2003","journal-title":"Pharmacol Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3590","article-title":"Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions","volume":"17","author":"Martins","year":"2016","journal-title":"Nat Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2174\/1381612811319150004","article-title":"Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicity","volume":"19","author":"Wagener","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00415","article-title":"Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development","volume":"5","author":"Schaer","year":"2014","journal-title":"Front Physiol"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V32.5.811.811","article-title":"Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases","volume":"32","author":"Muller-Eberhard","year":"1968","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ajh.2830420112","article-title":"Bioactivity of heme and its containment","volume":"42","author":"Muller-Eberhard","year":"1993","journal-title":"Am J Hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2248","article-title":"The heme-heme oxygenase system: a molecular switch in wound healing","volume":"102","author":"Wagener","year":"2003","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2018.07.002","article-title":"Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patients","volume":"72","author":"Santiago","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00300.2003","article-title":"Heme: a determinant of life and death in renal tubular epithelial cells","volume":"286","author":"Gonzalez-Michaca","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0196455","DOI":"10.1371\/journal.pone.0196455","article-title":"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction","volume":"13","author":"Belcher","year":"2018","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1993.79.2.0252","article-title":"Hemin: levels in experimental subarachnoid hematoma and effects on dissociated vascular smooth-muscle cells","volume":"79","author":"Letarte","year":"1993","journal-title":"J Neurosurg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00471.x","article-title":"Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1","volume":"59","author":"Nath","year":"2001","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00061","article-title":"Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes","volume":"5","author":"Chiabrando","year":"2014","journal-title":"Front Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00187","article-title":"Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders","volume":"6","author":"Smith","year":"2015","journal-title":"Front Physiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4165","article-title":"Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency","volume":"103","author":"Yachie","year":"1999","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000138547.51867.43","article-title":"Verotoxin (shiga toxin) sensitizes renal epithelial cells to increased heme toxicity: possible implications for the hemolytic uremic syndrome","volume":"15","author":"Bitzan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.1.237","article-title":"Accelerated autoxidation and heme loss due to instability of sickle hemoglobin","volume":"85","author":"Hebbel","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-008-0368-5","article-title":"A central role for free heme in the pathogenesis of severe malaria: the missing link","volume":"86","author":"Ferreira","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"51ra71","DOI":"10.1126\/scitranslmed.3001118","article-title":"A central role for free heme in the pathogenesis of severe sepsis","volume":"2","author":"Larsen","year":"2010","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96910","article-title":"Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles","volume":"3","author":"Merle","year":"2018","journal-title":"JCI Insight"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2005.06.022","article-title":"An improved colorimetric method for quantitation of heme using tetramethylbenzidine as substrate","volume":"344","author":"Huy","year":"2005","journal-title":"Anal Biochem"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.170","article-title":"Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells","volume":"51","author":"van Setten","year":"1997","journal-title":"Kidney Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e45423","DOI":"10.1371\/journal.pone.0045423","article-title":"Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development","volume":"7","author":"Desselle","year":"2012","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-10-17","article-title":"Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR","volume":"10","author":"Valente","year":"2009","journal-title":"BMC Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.02.010","article-title":"Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells","volume":"1812","author":"Wilmer","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2004.6.819","article-title":"Why heme needs to be degraded to iron, biliverdin IXalpha, and carbon monoxide","volume":"6","author":"Sassa","year":"2004","journal-title":"Antioxid Redox Signal"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nm799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-6147(00)01609-6","article-title":"Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation","volume":"22","author":"Wagener","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26857","article-title":"Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice","volume":"116","author":"Belcher","year":"2006","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw357","article-title":"Alterations in Systemic Extracellular Heme and Hemopexin Are Associated With Adverse Clinical Outcomes in Ugandan Children With Severe Malaria","volume":"214","author":"Elphinstone","year":"2016","journal-title":"J Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2005.03.004","article-title":"Free heme toxicity and its detoxification systems in human","volume":"157","author":"Kumar","year":"2005","journal-title":"Toxicol Lett"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03008","article-title":"Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1","volume":"9","author":"May","year":"2018","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1309\/8GLX5798Y5XHQ0VW","article-title":"Haptoglobin phenotypes in health and disorders","author":"Sadrzadeh","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"B42","article-title":"Hemopexin: a unique genetic polymorphism in populations of African ancestry","volume":"65","author":"Kamboh","year":"1993","journal-title":"Hum Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-489245","article-title":"Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome","volume":"122","author":"Frimat","year":"2013","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2011.01.008","article-title":"Control of intracellular heme levels: heme transporters and heme oxygenases","volume":"1813","author":"Khan","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-216-44197","article-title":"Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells","volume":"216","author":"Wagener","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-016-3420-7","article-title":"Fecal diagnostics in combination with serology: best test to establish STEC-HUS","volume":"31","author":"Wijnsma","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12124","article-title":"The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome","volume":"173","author":"Gomez","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00146","article-title":"Heme as a Target for Therapeutic Interventions","volume":"8","author":"Immenschuh","year":"2017","journal-title":"Front Pharmacol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-529982","article-title":"Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms7010015","article-title":"Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome","volume":"7","author":"Buelli","year":"2019","journal-title":"Microorganisms"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.547406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T02:39:15Z","timestamp":1608604755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.547406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2020.547406"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.547406","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,22]]},"article-number":"547406"}}